The downregulation of ABRO1 mRNA in hepatocellular carcinoma (HCC) tissues was confirmed by quantitative reverse transcriptase–PCR (qRT–PCR) in 22 pairs of HCC specimens and in the adjacent non-cancerous liver tissues (Fig. 1a and Supplementary Fig. 1b). Here, ABRAXAS2 is linked to hepatocellular carcinoma.